ARTIS is a family of dedicated angiography systems developed for single and biplane diagnostic imaging and interventional procedures including, but not limited to, pediatric and obese patients.

Procedures that can be performed with the ARTIS family include cardiac angiography, neuro-angiography, general anglography, rotational angiography, multipurpose angiography and whole body radiographic/fluoroscopic procedures as well as procedures next to the table for i.e. patient extremities. This does not include projection radiography.

Additional procedures that can be performed include angiography in the operating room, image guided surgery by X-ray, by image fusion, and by navigation systems. The examination table as an integrated part of the system can be used for Xray imaging, surgery and interventions.

ARTIS can also support the acquisition of position triggered imaging for spatial data synthesis.

The ARTIS family include also the software option DynaCT with following indications for use: DynaCT is an X-ray maging software option, which allows the reconstruction of two-dimensional images acquired with a standard angiographic C-arm device into a three-dimensional image format.

DynaCT is intended for imaging both hard and soft tissues as well as other internal body structures for diagnosis, surgical planning, interventional procedures and treatment follow-up.

Device Description

The ARTIS icono (VE21) system is a medical device that allows visualization of vessels within the human body. It is of the utmost importance to find the right projections so physician can navigate catheters and other devices safely. The ARTIS icono (VE21) system consist of a patient table and a multi-axis motorized c-arm that can be positioned around the patient and angulated in a double-oblique fashion iso-centering the region of interest between the x-ray tube and the flat panel detector. The x-ray generator is placed separately. The displays for visualizing the x-ray images are mounted at the ceiling with a movable display suspension system. System operation is executed via control modules table side so that the physician can move and position the table and c-arm adequately for best imaging while manipulate the catheters or other devices during x-ray. X-ray release is table side via a footswitch.

The ARTIS icono (VE21), modular angiography systems are designed as sets of components that may be combined into two different configurations (Biplane or Floor) to provide specialized angiography systems. In general, they are equipped with Carm, stand, flat panel detector, x-ray tube, collimator, high voltage generator, patient table, and image post processing.

The ARTIS icono (VE21) covers the complete range of angiographic applications, cardiac angiography, neuro-angiography, general angiography, surgery and surgical angiography, angiography. and radiographic/fluoroscopic procedures.

The following components are configured to create a Floor or Biplane configuration:

(1) Floor stand with C-arm, X-ray tube assembly and FD
(2) Patient table
(3) Display ceiling suspension with displays
(4) Footswitch for releasing radiation
(5) Control console for controlling the stand, patient table and imaging system

Images and operating elements are displayed on screens. Depending on the ARTIS icono (VE21) system configuration, different display variants are used to visualize image and information content. Displays that visualize single images or large displays that are configurable to visualize multiple images and information content in variaous layouts are used.

Post processing can be done in the exam room or in the control room that offers monitors as well, with a footswitch location in the exam room or the control room. The ARTIS icono (VE21) System is capable of 2D and 3D imaging. The c-arms can be mounted on the floor or for biplane systems on the floor and on the ceiling. Other systems and software syngo Application Software, synqo X Workplace, Sensis, and or third-party systems may also be integrated into the ARTIS icono (VE21) screen configuration. Different screen configurations and layouts are possible in the examination room and in the control room.

The Subject device ARTIS icono with software version VE21 will support the following modifications.

Software / Hardware changes specific to New System Software VE21
1.	Updated system Software from VE20 to VE21
	A. Lateral Plane syngo DynaCT (3D with Plane B (Biplane)
	B. NOMSIE DSA (IQ) Customization of Contrast in DSA Images
	C. Optional New Generator (Polydoros ACX)
2.	Update 510(k) Information

AI/ML Overview

The provided document is a 510(k) summary for the Siemens ARTIS icono (VE21) System, a medical device for angiography. It describes the device, its intended use, and its substantial equivalence to a predicate device (ARTIS icono VE20).

However, the document does not contain specific acceptance criteria, reported device performance metrics (numerical data like sensitivity, specificity, accuracy), or details of a study that directly prove the device meets acceptance criteria in the format requested.

It states that "All test results met all acceptance criteria" and mentions "Bench Test Summaries" but does not provide the details of these tests or criteria. It also does not include information about sample sizes for test/training sets, data provenance, number or qualifications of experts, adjudication methods, MRMC studies, standalone performance, or the specific type of ground truth used for performance evaluation on its new features (Lateral Plane syngo DynaCT and NOMSIE DSA).

The document is primarily focused on demonstrating substantial equivalence to a predicate device, as required for 510(k) clearance, by detailing changes and adherence to various safety and performance standards.

Therefore, I cannot populate the table or provide the requested information completely as it is not present in the provided text.

Based on the provided text, here's what can be extracted and what is missing:

Information NOT present in the document for the specific modifications (Lateral Plane syngo DynaCT, NOMSIE DSA (IQ) Customization, Optional New Generator):

Acceptance Criteria Table: Specific numerical acceptance criteria for the new features (e.g., image quality metrics like contrast-to-noise ratio, spatial resolution, or diagnostic accuracy for DynaCT).
Reported Device Performance: Specific numerical performance data demonstrating how the device met these criteria for the new features.
Sample Size for Test Set: Not mentioned for any specific performance evaluations of the new features.
Data Provenance (country of origin, retrospective/prospective): Not mentioned.
Number of Experts & Qualifications: Not mentioned for establishing ground truth for any performance evaluations of the new features.
Adjudication Method: Not mentioned.
MRMC Comparative Effectiveness Study: No mention of an MRMC study or effect size for AI assistance.
Standalone Performance Study: The document primarily discusses verification and validation of software and hardware changes, not a standalone performance study with clinical outcomes or diagnostic accuracy for the new features.
Type of Ground Truth Used (for the new features): Not specified (e.g., gold standard, pathology, clinical outcome, expert consensus).
Sample Size for Training Set: Not mentioned.
How Ground Truth for Training Set was Established: Not mentioned.

Information that can be inferred or directly stated from the document (mostly related to general safety and validation, not specific performance metrics of new features):

Study That "Proves" Device Meets Acceptance Criteria: The document states:
- "Verification and Validation: Software Documentation for a Major Level of Concern software per FDA's Guidance Document... is also included as part of this submission. The performance data demonstrates continued conformance with special controls for medical devices containing software. Non-clinical tests were conducted on ARTIS icono System software (VE21) during product development."
- "The Risk analysis was completed, and risk control implemented to mitigate identified hazards. The testing results support that all the software specifications have met the acceptance criteria. Testing for verification and validation for the device was found acceptable to support the claims of substantial equivalence."
- "ARTIS icono System software (VE21) was tested and found to be safe and effective for intended users, uses and use environments through the design control verification and validation process. The Human Factor Usability Validation showed that Human factors are addressed in the system test according to the operator's manual."
- "Performance tests were conducted to test the functionality of ARTIS icono (VE21) System. These tests have been performed to assess the functionality of the subject device. Results of all conducted testing and clinical assessment were found acceptable and do not raise any new issues of safety or effectiveness."
- "The modifications described in this Premarket Notification are supported with verification and validation testing."

Summary Table (with placeholders for missing information):

Acceptance Criteria Category	Reported Device Performance
New System Software VE21:
1A. Lateral Plane syngo DynaCT (3D with Plane B):	Specific acceptance criteria not provided
1B. NOMSIE DSA (IQ) Customization of Contrast in DSA Images:	Specific acceptance criteria not provided
1C. Optional New Generator (Polydoros ACX):	Specific acceptance criteria not provided
General Software Safety & Cybersecurity:	Conformance to "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices," "Off-The-Shelf Software Use in Medical Devices," and cybersecurity requirements per IEC 80001-1:2010.
Electrical Safety, Performance, EMC:	Compliance with various IEC/AAMI/ISO standards (e.g., AAMI ANSI ES60601-1:2005/(R)2012, IEC 60601-1-2:2014, ISO 14971:2019 etc.)

Summary

{0}------------------------------------------------

June 29, 2022

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services seal on the left and the FDA acronym with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out to the right of the square. The full name reads "U.S. Food & Drug Administration" with the word "Administration" on the second line.

Siemens Medical Solutions USA, Inc. % Patricia Jones Regulatory Affairs Professional 40 Liberty Boulevard MALVERN PA 19355

Re: K220432

Trade/Device Name: ARTIS icono (VE21) System Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: Class II Product Code: OWB, IZI, JAA, JAK Dated: June 15, 2022 Received: June 17, 2022

Dear Patricia Jones:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Laurel Burk, Ph.D. Assistant Director Diagnostic X-Ray Systems Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K220432

Device Name ARTIS icono (VE21) System

Indications for Use (Describe)

ARTIS is a family of dedicated angiography systems developed for single and biplane diagnostic imaging and interventional procedures including, but not limited to, pediatric and obese patients.

ARTIS can also support the acquisition of position triggered imaging for spatial data synthesis.

DynaCT is intended for imaging both hard and soft tissues as well as other internal body structures for diagnosis, surgical planning, interventional procedures and treatment follow-up.

Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)	Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the words is a cluster of orange dots arranged in a circular pattern.

510(k) Summary: ARTIS icono (VE21)

Siemens Medical Solutions USA, Inc. Company: 40 Liberty Boulevard, 65 Malvern, PA 19355

Date Prepared: June 15, 2022

This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR § 807.92.

1. General Information: Importer / Distributor: Siemens Medical Systems USA, Inc. 40 Liberty Boulevard, 65-1A Malvern, PA 19355 Establishment Registration Number: 2240869

Manufacturing Site: Siemens Healthcare GmbH Siemensstr. 1 91301 Forchheim, Germany Establishment Registration Number: 3004977335

2. Contact Person:

Ms. Patricia D. Jones Regulatory Affairs Professional Siemens Medical Solutions USA, Inc. 40 Liberty Boulevard Malvern, PA 19355 Phone: (678) 575-8832 Email: patricia.jones@siemens-Healthineers.com

Device Name and Classification: 3.

Trade Name: Classification Name: Classification Panel: Regulation Number: Device Class: Product Codes:

ARTIS icono (VE21) System

Image-intensified fluoroscopic x-ray System Radiology 21 CFR §892.1650 Class II OWB, IZI, JAA, JAK

4. Legally Marketed Primary Predicate Device

Trade Name: ARTIS icono (VE20) System 510(k) Clearance K190768 Clearance Date September 12, 2019 Classification Name: Image-intensified fluoroscopic x-ray System Classification Panel: Radiology Regulation Number: 21 CFR §892.1650

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the words is a graphic of orange dots arranged in a circular pattern.

Device Class: Product Code: Subsequent Product Codes: Class II OWB IZI, JAA, JAK

Total Product Life Cycle:

All product Recall incidents are considered during the Design Input phase of development to ensure the latest models will not be affected by any of the applicable issues.

5. Device Description:

The ARTIS icono (VE21) system is a medical device that allows visualization of vessels within the human body. It is of the utmost importance to find the right projections so physician can navigate catheters and other devices safely. The ARTIS icono (VE21) system consist of a patient table and a multi-axis motorized c-Traditional 510(k) ARTIS icono (VE21) System arm that can be positioned around the patient and angulated in a double-oblique fashion iso-centering the region of interest between the x-ray tube and the flat panel detector. The x-ray generator is placed separately. The displays for visualizing the x-ray images are mounted at the ceiling with a movable display suspension system. System operation is executed via control modules table side so that the physician can move and position the table and c-arm adequately for best imaging while manipulate the catheters or other devices during x-ray. X-ray release is table side via a footswitch.

The following components are configured to create a Floor or Biplane configuration:

(1) Floor stand with C-arm, X-ray tube assembly and FD
(2) Patient table
(3) Display ceiling suspension with displays
(4) Footswitch for releasing radiation
(5) Control console for controlling the stand, patient table and imaging system

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image contains the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the words is a graphic of several orange dots of varying sizes arranged in a circular pattern.

The Subject device ARTIS icono with software version VE21 will support the following modifications.

Software / Hardware changes specific to New System Software VE21
1.	Updated system Software from VE20 to VE21
	A. Lateral Plane syngo DynaCT (3D with Plane B (Biplane)
	B. NOMSIE DSA (IQ) Customization of Contrast in DSA Images
	C. Optional New Generator (Polydoros ACX)
2.	Update 510(k) Information

6. Indications for Use:

ARTIS is a family of dedicated angiography systems developed for single and biplane diagnostic imaging and interventional procedures including, but not limited to. pediatric and obese patients.

Procedures that can be performed with the ARTIS family include cardiac angiography, neuro-angiography, general angiography, rotational angiography, multipurpose angiography and whole body radiographic/fluoroscopic procedures as well as procedures next to the table for i.e., patient extremities. This does not include projection radiography.

ARTIS can also support the acquisition of position triggered imaging for spatial data synthesis.

The ARTIS family include also the software option DynaCT with following indications for use:

DynaCT is an X-ray imaging software option, which allows the reconstruction of twodimensional images acquired with a standard angiographic C-arm device into a threedimensional image format.

DynaCT is intended for imaging both hard and soft tissues as well as other internal body structures for diagnosis, surgical planning, interventional procedures and treatment follow-up.

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image shows the Siemens Healthineers logo. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the word "Healthineers" is a graphic of orange dots.

Substantial Equivalence: 7.

The ARTIS icono (VE21) System is substantial equivalent to the legally marketed (primary) predicate listed in the table below:

Predicate Device Nameand Manufacturer	510(k)Number	ClearanceDate	Comparable Properties
ARTIS icono (VE20)Siemens	K190768	09/12/2019	• Indications for Use• System Software VE20• Planes A & B• Image Quality• Generator

Table 3: Predicate Device Comparable Properties for Subject Device Modifications:

Summary of Technological Characteristics of the Subject Device as Compared 8. with the Predicate Device:

The ARTIS icono (VE21) System is designed as a set of components (C-arm, X-ray tube and housing, flat panel detector, digital imaging system, collimator, generator etc.) that may be combined into two different configurations (Floor & Biplane to provide specialized angiography systems. Components used with ARTIS icono (VE21) System are either commercially available with current Siemens systems or include modifications to existing components. Technological differences between the Subject Device and the Predicate Device is provided in the Table 4 below for all modifications.

Modifications	Subject DeviceARTIS icono (VE21)	Predicate DeviceARTIS icono (VE20)K190768	ComparisonResults
New SystemSoftwareChanges	1. Updated system Softwarefrom VE20 to VE21	System SoftwareVersion VE20	Comparable:System software VE21 wasupdated to support LateralPlane syngo DynaCT (3Dwith plane B (Biplane only);NOMSIE DSA (IQ)Customization of Contrast inDSA Images and a newGenerator. System Softwaremodifications conforms to"Guidance for the content ofPremarket submission forsoftware in MedicalDevices". Provided is allrequired software testing.Provided in this submissionare Bench Test Summaries.These software andhardware changes do notraise any new risks or anyissues regarding the safetynor effectiveness of the
	A. Lateral Plane syngoDynaCT (3D withplane B (Biplane)	No syngo DynaCT onLateral Plane B (Biplane)
	B. NOMSIE DSA (IQ)Customization ofContrast in DSAImages	Classical edgeenhancement with filtersand automaticwindowing was used.
	C. Optional NewGenerator(Polydoros ACX)	Generator (PolydorosA100G)

Table 4: Summary of Comparison of Technological Characteristics

{7}------------------------------------------------

Image /page/7/Picture/0 description: The image shows the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the word "Healthineers" is a graphic of orange dots arranged in a circular pattern.

Modifications	Subject DeviceARTIS icono (VE21)	Predicate DeviceARTIS icono (VE20)K190768	ComparisonResults
			device. All test results metall acceptance criteria.
Update 510(k)Information			2. Updated 510(k) information for the Primary Predicate Device is provided.

9. Nonclinical Performance Testing:

Non-clinical tests were conducted for the ARTIS icono VE21) during product development.

The ARTIS icono (VE21) was certified by Siemens Healthcare GmbH Corporate Testing Laboratory to comply with the following standards for Electrical safety, performance and Electromagnetic Compatibility:

AAMI ANSI ES60601-1:2005/(R)2012 ●
IEC 60601-1-2:2014
IEC 60601-1-3:2013 ●
IEC 60601-1-6:2010/A1:2013 ●
IEC 60825-1:2014 ●
TR 60878:2015 ●
IEC 62304:2015 ●
IEC 80001-1:2010 ●
IEC 60601-2-28:2017 ●
IEC 60601-2-43:2019 ●
IEC 60601-2-54:2018 ●
ISO 10993-1:2018 ●
ISO 14971:2019

The modifications described in this Premarket Notification are supported with verification and validation testing.

Verification and Validation:

Software Documentation for a Major Level of Concern software per FDA's Guidance Document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" issued on May 11, 2005, and "Off-The-Shelf Software Use in Medical Devices" is also included as part of this submission. The performance data demonstrates continued conformance with special controls for medical devices containing software. Non-clinical tests were conducted on ARTIS icono System software (VE21) during product development.

The Risk analysis was completed, and risk control implemented to mitigate identified hazards. The testing results support that all the software specifications have met the acceptance criteria. Testing for verification and validation for the device was found acceptable to support the claims of substantial equivalence.

{8}------------------------------------------------

Image /page/8/Picture/0 description: The image contains the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the text is a cluster of orange dots of varying sizes, arranged in a circular pattern.

ARTIS icono System software (VE21) was tested and found to be safe and effective for intended users, uses and use environments through the design control verification and validation process. The Human Factor Usability Validation showed that Human factors are addressed in the system test according to the operator's manual. Customer employees are adequately trained in the use of this equipment.

Siemens conforms to the cybersecurity requirements by implementing a process of preventing unauthorized access, modifications, misuse or denial of use, or the unauthorized use of information that is stored, accessed or transferred from a medical device to an external recipient. Provided in this submission is a cybersecurity statement that considers IEC 80001-1:2010. The responsibility for compliance with IEC 80001-1-2010 is the hospital. Provided in the Software Section is the required cybersecurity information.

Summary:

Performance tests were conducted to test the functionality of ARTIS icono (VE21) System. These tests have been performed to assess the functionality of the subject device. Results of all conducted testing and clinical assessment were found acceptable and do not raise any new issues of safety or effectiveness.

10. General Safety and Effectiveness Concerns:

Instructions for use are included within the device labeling, and the information provided will enable the user to operate the device in a safe and effective manner.

Risk management is ensured via a hazard analysis, which is used to identify potential hazards. These potential hazards are controlled via software development, verification and validation testing. To minimize electrical, mechanical and radiation hazards, Siemens adheres to recognized and established industry practice, and all equipment is subject to final performance testing. Furthermore, the operators are health care professionals familiar with and responsible for the evaluating and post processing of X-ray images.

11. Conclusion as to Substantial Equivalence:

The predicate devices were cleared based on non-clinical supportive information and clinical images and data. Similar non-clinical test results demonstrate that the ARTIS icono (VE21) System acceptance criteria are adequate for the intended use of the device. The comparison of technological characteristics, non-clinical performance data and software validation data demonstrates that the Subject Device is as safe and effective when compared to the Predicate Devices that is currently marketed for the same intended use.

Regulation Number and Section

§ 892.1650 Image-intensified fluoroscopic x-ray system.

(a)
Identification. An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.